---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-25-005043"
form_type: "8-K"
ticker: "BCTX"
cik: "0001610820"
company_name: "BriaCell Therapeutics Corp."
filed_at: "2025-02-05T23:59:59+00:00"
generated_at: "2026-05-27T02:42:20.313857+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# BriaCell raises $3.05M in public offering of 762,500 common shares at $4.00/share

## Summary
- Closed best-efforts offering of 762,500 common shares at $4.00/share on Feb 5, 2025; gross proceeds $3.05M.
- Net proceeds to be used for working capital, general corporate purposes, and advancement of business objectives.
- ThinkEquity acted as sole placement agent; received 7.5% cash fee and warrants to purchase 38,125 shares at $5.00/share (5-year term).
- Offering conducted under effective shelf registration S-3; TSX exemption relied upon for listing.

## SEC filing metadata
- accession: 0001493152-25-005043
- form_type: 8-K
- ticker: BCTX
- cik: 0001610820
- company_name: BriaCell Therapeutics Corp.
- filed_at: 2025-02-05T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 1.01, 3.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1610820/000149315225005043/0001493152-25-005043-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1610820/000149315225005043/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-25-005043
- JSON: https://secwatch.observer/filing/0001493152-25-005043.json
- Plain text: https://secwatch.observer/filing/0001493152-25-005043.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.